Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV | Infectious Diseases and Therapy
Switch pour BIC/FTC/TAF - ppt télécharger
Randomized clinical trials of BIC/FTC/TAF and DTG/3TC in naïve patients. | Download Scientific Diagram
INSIGHT: Wk 24 Efficacy, Safety, and PK of BIC/FTC/TAF in Adults With HIV and Tuberculosis Receiving Rifampicin | CCO
VIH : AMM européenne pour le Biktarvy
Outcomes After Switching to BIC/FTC/TAF in Patients with Virological F | IDR
ARV-Trials.com
Full article: Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study
Efficacy and safety of using bictegravir / emtricitabine / tenofovir alafenamide (BIC/FTC/TAF) in a test and treat model: the FAST Study
Etude SOLAR: la stratégie de switch vers CAB/RPV LA se révèle non inférieure à une poursuite de la trithérapie BIC/FTC/TAF - VIH - jm update Spécialiste - lejournaldumedecin.com
JCM | Free Full-Text | Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV
Efficacy and safety of using bictegravir / emtricitabine / tenofovir alafenamide (BIC/FTC/TAF) in a test and treat model: the FAST Study
Diagram comparing initial use BIC/TAF/FTC with switching to BIC/TAF/FTC... | Download Scientific Diagram
Gilead's fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability - European Pharmaceutical Review
Randomized clinical trials of BIC/FTC/TAF and DTG/3TC in naïve patients. | Download Scientific Diagram
Efficacy and safety of using bictegravir / emtricitabine / tenofovir alafenamide (BIC/FTC/TAF) in a test and treat model: the FAST Study